Zhihui Chen


2026

Text-guided image editors can now manipulate authentic medical scans with high fidelity, enabling lesion implantation/removal that threatens clinical trust and safety. Existing defenses are inadequate for healthcare. Medical detectors are largely black-box, while MLLM-based explainers are typically post-hoc, lack medical expertise, and may hallucinate evidence on ambiguous cases. We present MedForge, a data-and-method solution for pre-hoc, evidence-grounded medical forgery detection. We introduce MedForge-90K, a large-scale benchmark of realistic lesion edits across 19 pathologies with expert-guided reasoning supervision via doctor inspection guidelines and gold edit locations. Building on it, MedForge-Reasoner performs localize-then-analyze reasoning, predicting suspicious regions before producing a verdict, and is further aligned with Forgery-aware GSPO to strengthen grounding and reduce hallucinations. Experiments demonstrate state-of-the-art detection accuracy and trustworthy, expert-aligned explanations.

2025

Detecting LLM-generated text in specialized and high-stakes domains like medicine and law is crucial for combating misinformation and ensuring authenticity. However, current zero-shot detectors, while effective on general text, often fail when applied to specialized content due to domain shift. We provide a theoretical analysis showing this failure is fundamentally linked to the KL divergence between human, detector, and source text distributions. To address this, we propose DivScore, a zero-shot detection framework using normalized entropy-based scoring and domain knowledge distillation to robustly identify LLM-generated text in specialized domains. Experiments on medical and legal datasets show that DivScore consistently outperforms state-of-the-art detectors, with 14.4% higher AUROC and 64.0% higher recall at 0.1% false positive rate threshold. In adversarial settings, DivScore demonstrates superior robustness to other baselines, achieving on average 22.8% advantage in AUROC and 29.5% in recall.